Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
Autor: | Karin Zebenholzer, Walter Gall, Christian Wöber |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-9 (2018) |
Druh dokumentu: | article |
ISSN: | 1129-2369 1129-2377 |
DOI: | 10.1186/s10194-018-0864-0 |
Popis: | Abstract Background To evaluate triptan use and overuse as well as prescription patterns in Austria based on a nationwide healthcare database because data on triptan use and overuse in Austria is missing. Methods We included all persons insured with one of 19 Austrian social security institutions in 2007. Inclusion criteria comprised an age of 18–99 years, known sex, and receipt of insurance benefits. We defined triptan use as ≥1 package of a triptan dispensed in 2007 and triptan overuse as ≥30 defined daily doses dispensed in at least one quarter. Results Out of 8.295 million inhabitants in Austria, 7,426,412 persons (89.5%) were insured with a social insurance carrier and 5,918,487 persons of those insured (79.7%) fulfilled the inclusion criteria. Among the latter 33,062 persons (0,56%) were triptan users and 1970 (0.033%) were triptan overusers. The estimated proportion of persons with migraine using a triptan was less than 6%. Among users 5.9% were overusers of whom 55% overused triptans in ≥2 quarters of 2007. The median number of days of sick-leave was higher in triptan users than in non-users: due to any reason of sick-leave 12 vs. 10, p |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |